FibroBiologics (FBLG) Capital Expenditures (2023 - 2025)
FibroBiologics' (FBLG) quarterly Capital Expenditures came in at $6000.0 in Q3 2025, down 45.45% on a YoY basis from $11000.0 in Q3 2024, and down 97.18% quarter-over-quarter from $213000.0 in Q2 2025.
Powered by 
Analysis
FibroBiologics (FBLG) Capital Expenditures (2023 - 2025) Analysis & Trends
FibroBiologics (FBLG) has reported Capital Expenditures for 3 consecutive years, with $6000.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures fell 45.45% year-over-year to $6000.0; the trailing twelve-month figure through Jun 2026 stood at $6000.0 (down 98.36% YoY), and the FY2025 full-year result was $262000.0, up 42.39% from the prior year.
- Capital Expenditures retreated to $6000.0 in Q3 2025 per FBLG's latest filing, from $213000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $413000.0 in Q3 2023 and bottomed at $2000.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $85545.5 across 3 years, with a median of $43000.0 in 2025.
- The widest YoY moves for Capital Expenditures: up 4850.0% in 2024, down 97.34% in 2024.
- Over 3 years, Capital Expenditures stood at $2000.0 in 2023, then surged by 4850.0% to $99000.0 in 2024, then slumped by 93.94% to $6000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $6000.0, $213000.0, and $43000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.25 Bn | 9.40 Bn | 112.79 Mn | 3.57 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - | 648,000.00 |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn | 5.44 Mn |
| 4 | Legend Biotech | 3.58 Bn | 2.62 Bn | 251.50 Mn | -7.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 472,000.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | 2.41 Mn |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn | 392,000.00 |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn | 555,000.00 |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 1.73 Mn |
| 10 | FibroBiologics | 11.04 Mn | 11.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 99,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Mar 31, 2023 | 56,000.00 |